Where does Gurdane Bhutani work?

Gurdane Bhutani is Co-Founder and Managing Partner at MBX Capital and Board director at Junction Health and Board director at Neurofold Therapeutics and Board director at Contraline.

What check size does Gurdane Bhutani write?

Gurdane Bhutani typically writes checks of $250K – $2M.

What boards does Gurdane Bhutani sit on?

Gurdane Bhutani holds tracked board seats at Contraline, Junction Health, Neurofold Therapeutics.

Where did Gurdane Bhutani go to school?

Gurdane Bhutani studied at Yale University (MPH, Epidemiology); Duke University (BA, Computer Science); University of Oxford.

Gurdane Bhutani

Investor

Co-Founder and Managing Partner at MBX Capital · Board director at Junction Health · Board director at Neurofold Therapeutics · Board director at Contraline

New York, New York

Writes $250K – $2M checks · typically $1.5M

About

Gurdane Singh Bhutani applies a bi-national healthcare-policy perspective, pioneering a community-driven model that pairs startups with physician and scientist co-investors and backs exposome-focused firms mapping toxins and high-throughput chemical testing.

Contact· self-published, not guessed

g•••@mbxcapital.comreveal

Invests in

AI & Machine LearningBiotechHealthtechMedical DevicesRobotics

Board director at Junction Health

Intro paths

→

In turn, Gurdane can intro founders to Junction Health's investors below.

Junction Health's investors · 1

MBX CapitalClaymont · $250K – $2.5M checks · since 2026

Co-founders at Junction Health

Ben WiederholtCo-founder & CEO

Vinny PolitoCo-founder & COO

Matt VestalCo-founder & Chief Commercial Officer

Board director at Neurofold Therapeutics

Intro paths

→

In turn, Gurdane can intro founders to Neurofold Therapeutics's investors below.

Neurofold Therapeutics's investors · 1

MBX CapitalClaymont · $250K – $2.5M checks · since 2026

Board director at Contraline

Intro paths

→

In turn, Gurdane can intro founders to Contraline's investors below.

Contraline's investors · 21

Allied Venture PartnersCalgary · $100K – $350K checks Amboy Street VenturesVenice Aurum Venture PartnersPleasanton Beni Venture CapitalMiami · $100K – $250K checks Biotechnology Value FundSan Francisco · since 2026 Cleo CapitalNew York · $100K – $1M checks Evolution VC PartnersNew York Foreground CapitalBoston Graphene VenturesPalo Alto · $500K – $2M checks GV (Google Ventures)Mountain View · $250K – $50M checks · since 2026 Helium-3 VenturesNew York JourneyOne VenturesBoulder Kima VenturesParis · $50K – $5M checks Lumira VenturesToronto · $1M – $10M checks · since 2026 MBX CapitalClaymont · $250K – $2.5M checks · since 2026 MetaplanetTallinn · $500K – $10M checks Myelin VCMontevideo · $250K – $1M checks RA CapitalBoston · since 2026 ShangBay Capital LLCPalo Alto Strawberry Creek VenturesManchester VU Venture PartnersSan Francisco · $200K – $1M checks

Co-founders at Contraline

Kevin S EisenfratsExecutive Officer, Director, Promoter

Kevin EisenfratsCo-Founder and CEO

John HerrCo-Founder

Experience

VivodyneSpecial Projects, Office of the CEOcurrent2026 — presentSan Francisco, CA
VivodyneObserver, Board of Directorscurrent2024 — presentSan Francisco, CA
MBX CapitalCo-founder & Managing Partnercurrent2020 — presentNew York, NY
Contraline, Inc.Member, Board of Directorscurrent2020 — presentCharlottesville, VA
Ancilia BiosciencesMember, Board of Directorscurrent2026 — presentNew York, NY
Junction HealthMember, Board of Directorscurrent2024 — presentDenver, CO
Yale School of ManagementLecturer in the Practice of Managementcurrent2025 — presentNew Haven, CT
Kauffman FellowsFellowcurrent2018 — presentPalo Alto, CA
Persist AIObserver, Board of Directorscurrent2025 — presentSacramento, CA
Juniper GenomicsObserver, Board of Directorscurrent2025 — presentToronto, ON
ThesisObserver, Board of Directorscurrent2023 — presentNew York, NY
CareRevObserver, Board of Directors2019 — 2025Los Angeles, CA
Freedom BiosciencesObserver, Board of Directors2021 — 2024New Haven, CT
Atlas HealthObserver, Board of Directors2019 — 2024San Francisco, CA
Cleveland Clinic Lerner College of MedicineInstructor2017 — 2021Cleveland, OH
FundRxCo-founder & Chief Operating Officer2015 — 2020New York, NY
Bain & CompanyAssociate2013 — 2015New York, NY
Morgan StanleySummer Analyst2012New York, NY

Skills & more

Venture CapitalBiotechnologyHealthcare

From Gurdane's professional profile.

Deals · 3

Neurofold TherapeuticsBoard seat

via MBX Capital · filed Jul 2026 · $6.5M raise

ContralineBoard seat

via MBX Capital · filed Jun 2026 · $115.9M raise

press ↗

Junction HealthBoard seat

via MBX Capital · filed May 2026 · $3.6M raise

Attribution from SEC filings, press coverage, and firm rosters.

Colleagues at MBX Capital

Martin Gargaros

Director at MBX Capital

Zeshan Muhammedi

Managing Partner at MBX Capital

Frequently asked questions

Who is Gurdane Bhutani?: Gurdane Singh Bhutani applies a bi-national healthcare-policy perspective, pioneering a community-driven model that pairs startups with physician and scientist co-investors and backs exposome-focused firms mapping toxins and high-throughput chemical testing.
Where does Gurdane Bhutani work?: Gurdane Bhutani is Co-Founder and Managing Partner at MBX Capital and Board director at Junction Health and Board director at Neurofold Therapeutics and Board director at Contraline.
What does Gurdane Bhutani invest in?: Gurdane Bhutani invests in AI & Machine Learning, Biotech, Healthtech, Medical Devices, Robotics.
What check size does Gurdane Bhutani write?: Gurdane Bhutani typically writes checks of $250K – $2M.
What boards does Gurdane Bhutani sit on?: Gurdane Bhutani holds tracked board seats at Contraline, Junction Health, Neurofold Therapeutics.
Where did Gurdane Bhutani go to school?: Gurdane Bhutani studied at Yale University (MPH, Epidemiology); Duke University (BA, Computer Science); University of Oxford.